Glycoproteins: Emerging Markers of Inflammation Independent of Cardiovascular Risk

Cardiovascular events occur despite the control of conventional risk factors. Inflammation plays numerous roles in the pathogenesis of atherosclerotic cardiovascular disease. As an alternative to traditional inflammatory markers, new biomarkers of systemic inflammation, including Glyc-A and Glyc-B measured by nuclear magnetic resonance (NMR), have been explored. Especially, the concentration of Glyc-A has been associated as […]

What is metabolomics and how is it applied in diabetes?

Metabolomic profiling involves identifying intermediary molecules and end-products of metabolism, encompassing lipids, lipoproteins, fatty acid variants, amino acids, and glycoprotein acetyls. This approach holds promise for discovering novel biomarkers indicative of disease risk and offers fresh perspectives on molecular mechanisms, biological processes, and implicated disease pathways. Diabetes, affecting over 500 million people in 2021, stands […]

Biosfer Teslab at the event “Empowering the Future We Want”

On Monday, October 16, 2023, our CEO Núria Amigó participated in the event “Empowering the Future We Want” alongside Jose Bayon Lopez, CEO of ENISA, and Juan Merodio. The purpose of this event was to introduce the #SpainUpNation program. ENISA, the National Innovation Company, is a public entity under the Ministry of Industry, Commerce, and […]

Discordance between LDL-C levels and LDL particle number

LDL lipoproteins

The size of LDL lipoproteins varies and is dependent on the lipid content they carry inside, which in turn influences the particle density. LDL cholesterol (LDL-c) refers to the concentration or amount of cholesterol transported by low-density lipoproteins (LDL). LDL particles are the carriers of LDL cholesterol, and within LDL particles, there are differences in […]

Cardiovascular Disease: Beyond LDL Cholesterol

logoLiposcale test

Cardiovascular disease (CVD) claims the lives of over 4 million people in Europe every year. Dyslipidemia, a disorder characterized by abnormal blood lipid levels, is one of the most significant risk factors for the development of CVD. Specifically, LDL cholesterol plays a central role in the relationship between cardiovascular disease and dyslipidemia. However, a high […]

Biosfer Teslab at the International Manuel Rico NMR School

Manuel Rico NMR School

Biosfer Teslab asiste a la International Manuel Rico NMR School From June 19th to 23rd, the XV edition of the International Manuel Rico NMR School, organized by The Specialised Group of NMR (GERMN) of the Spanish Royal Society ofChemistry (RSEQ) took place in Jaca. The event brought together doctoral students, postdoctoral researchers, technical staff, and […]

Spring Highlights: international actions, conferences, and courses

Spring Highlights: international actions, conferences, and courses Biosfer Teslab a leading innovator in metabolomic based health applications and NMR services, is pleased to share its fruitful participation in different prominent conferences, meetings and courses held during the spring season. The company’s active engagement and contributions to these events have solidified its position as a thought […]

Biosfer Teslab at the Swiss Biotech day

swiss-biotech-day-1-2023

Swiss Biotech Day 24 y 25 de abril de 2023 Last 24th and 25th April, the Swiss Biotech Day took place in Basel (Switzerland). An event that has been held since 2013 organised by the Swiss Biotechnology Association and BIOCOM AG and which continues to grow year after year. The Swiss Biotech Day has become […]